• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Medical Imaging Markets, Volume IV – Contrast Agents

$1,995.00 – $5,990.00

Clear
SKU: KLI1340230 Categories: Diagnostics Market Research, Medical Imaging & In Vivo Testing Pages: 125
  • Description
  • Table of Contents
  • Latest reports

Description

Contrast agents and radiopharmaceuticals have revolutionized in vivo imaging. Technical developments in contrast media and imaging techniques is combining with the trends toward both the functional and molecular understanding of disease to create a rapidly growing marketplace in these agents.

The introduction and now brisk ongoing development of contrast media for traditional radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron-emission tomography (PET), and single-photon emission computed tomography (SPECT), are now allowing for the expansion of diagnostic capabilities of these modalities. Dozens of agents are being developed with the hopes of opening up new applications for existing modalities. While some agents will compete with existing agents while others aim to break new ground and provide a diagnostic assessment that is not currently available today.

This comprehensive study of the world market for contrast agents builds on the previous modality-focused reports of Kalorama’s Medical Imaging Markets series and includes:

  • World and regional revenue forecasts for contrast agents and radiopharmaceuticals by modality through 2010.
  • Market share of the major contrast agent supplers
  • Procedure volumes by modality and region
  • Estimates of the portion of procedures in each modality using contrast enhancement
  • Contrast-enhancement products in development

The report also discusses technical developments and emerging application trends such as therapeutic monitoring, whole body screening, and guided therapeutic interventions, and how contrast agents are helping to expand imaging’s role in basic research and drug discovery/development. Specific advances in contrast agent-enabled diagnostics for mammography, Alzheimer’s, and other indications are also reviewed.

The report concludes with profiles of top suppliers and developers including:

  • Acusphere Inc.
  • Advanced Magnetics Inc.
  • ART Advanced Research Technologies Inc.
  • Bristol-Myers Squibb
  • Boston Life Sciences
  • Bracco SpA
  • Cell Point
  • Cytogen Corp.
  • Daiichi Pharmaceutical Co. Ltd.
  • Dendritic NanoTechnologies Inc.
  • Dowpharma
  • Draximage
  • Epix Pharmaceuticals Inc.
  • E-Z-EM Inc.
  • GE Healthcare
  • Guerbet Group
  • Hovione FarmaCiencia SA
  • Imcor Pharmaceutical Co.
  • Immunomedics Inc.
  • King Pharmaceuticals Inc.
  • Luna nanoWorks
  • Macrocyclics
  • Mallinckrodt
  • Palatin Technologies Inc.
  • Pharmacyclics
  • Point Biomedical Corp.
  • Schering AG

Table of Contents

Chapter One: Executive Summary

  • 1.1 The Role of Contrast
  • 1.2 Use by Modality
    • 1.2.1 X-Ray and CT
    • 1.2.2 Ultrasound
    • 1.2.3 MRI
    • 1.2.4 Radiopharmaceuticals
  • 1.3 World Market Summary
    • 1.3.1 Market Drivers
    • 1.3.2 Market Challenges
    • 1.3.3 World Market Growth Analysis
  • 1.4 Methodology

Chapter Two: Introduction

  • 2.1 Overview
  • 2.2 Perspective
  • 2.3 Key Markets for Contrast Agents
    • 2.3.1 Radiography (X-Ray) and Computed Tomography (CT)
    • 2.3.2 Ultrasound
    • 2.3.3 Magnetic Resonance Imaging (MRI)
    • 2.3.4 Nuclear Medicine
    • 2.3.4.1 Positron Emission Tomography (PET)
    • 2.3.4.2 Single Photon Emission Computed Tomography SPECT
    • 2.3.4.3 Gamma Cameras
  • 2.4 Ionic and Non-Ionic Contrast Agents
  • 2.5 Issues and Challenges
    • 2.5.1 Adverse Events
    • 2.5.2 Therapeutic Monitoring
    • 2.5.3 Drug Delivery and Image Guided Interventions
    • 2.5.4 Whole Body Screening
    • 2.5.5 Technology Development
    • 2.5.6 Combination Technology

Chapter Three: Promising Developments

  • 3.1 Nuclear Imaging for Appendicitis
  • 3.2 PET for Alzheimer’s
  • 3.3 Contrast-Enhanced MRI Mammogram
  • 3.4 Combined Contrast Enhanced MRI
  • 3.5 Contrast Angiography
  • 3.6 Avoiding Multiple MRIs
  • 3.7 Chemical Shift Imaging
  • 3.8 Perfusion CT
  • 3.9 Multimodal Contrast

Chapter Four: Markets

  • 4.1 Market Drivers
    • 4.1.1 Targeted Imaging
    • 4.1.2 The Promise of Increased Diagnostic Efficacy
    • 4.1.3 Older Population
    • 4.1.4 System Upgrades
  • 4.2 Procedures and Reimbursement
  • 4.3 Market Size and Outlook for Contrast Media
    • 4.3.1 Agents in Development
    • 4.3.2 Total Market Size and Forecast
    • 4.3.3 Segment Market Forecasts
    • 4.3.3.1 Radiography (X-Ray)
    • 4.3.3.2 Computed Tomography (CT)
    • 4.3.3.3 Ultrasound
    • 4.3.3.4 Magnetic Resonance Imaging (MRI)
  • 4.4 Market Size and Outlook for Molecular Imaging Agents
    • 4.4.1 Products and Development
    • 4.4.2 Market Forecast
  • 4.5 Competitive Positions

Chapter Five: Company Profiles

  • Acusphere Inc.
  • Advanced Magnetics Inc.
  • ART Advanced Research Technologies Inc.
  • Bristol-Myers Squibb
  • Boston Life Sciences
  • Bracco SpA
  • Cell Point
  • Cytogen Corp.
  • Daiichi Pharmaceutical Co. Ltd.
  • Dendritic NanoTechnologies Inc.
  • Dowpharma
  • Draximage
  • Epix Pharmaceuticals Inc.
  • E-Z-EM Inc.
  • GE Healthcare
  • Guerbet Group
  • Hovione FarmaCiencia SA
  • Imcor Pharmaceutical Co.
  • Immunomedics Inc.
  • King Pharmaceuticals Inc.
  • Luna nanoWorks
  • Macrocyclics
  • Mallinckrodt
  • Palatin Technologies Inc.
  • Pharmacyclics
  • Point Biomedical Corp.
  • Schering AG

List of Exhibits

Chapter One: Executive Summary

  • Exhibit 1: Market Summary: World Market for Medical Contrast Media 2006-2010

Chapter Two: Introduction

  • Exhibit 2: Key Medical Contrast Agents by Type
  • Exhibit 3: Advantages of Non-Ionic Contrast Media

Chapter Four: Markets

  • Exhibit 4: Estimated Worldwide Medical X-Ray Procedure Volume by Region (U.S., E.U., ROW) 2005
  • Exhibit 5: Estimated Worldwide Medical MRI Procedure Volume by Region (U.S., E.U., ROW) 2005
  • Exhibit 6: Estimated Worldwide Medical CT Procedure Volume by Region (U.S., E.U., ROW) 2005
  • Exhibit 7: Estimated Worldwide Medical PET Procedure Volume by Region (U.S., E.U., ROW) 2005
  • Exhibit 8: Estimated Percentage of Imaging Procedures Employing Contrast Agents by Modality (X-Ray, CT, MRI, Ultrasound, PET, SPECT)
  • Exhibit 9: Status of Selected Medical Imaging Agents in Development (Company, Product, Status)
  • Exhibit 10: World Market for Medical Contrast Media and Radiopharmaceuticals 2005-2010
  • Exhibit 11: World Market Share for Medical Contrast Media and Radiopharmaceuticals by Modality (CT, MRI, PET, SPECT, Ultrasound, X-Ray), 2006
  • Exhibit 12: World Market Share for Medical Contrast Media and Radiopharmaceuticals by Modality (CT, MRI, PET, SPECT, Ultrasound, X-Ray), 2010
  • Exhibit 13: World Market for X-Ray Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
  • Exhibit 14: World Market for Medical X-Ray Contrast Media by Geographic Segment
  • Exhibit 15: World Market for CT Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
  • Exhibit 16: World Market for Medical CT Contrast Media by Geographic Segment
  • Exhibit 17: World Market for Ultrasound Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
  • Exhibit 18: World Market for Medical Ultrasound Contrast Media by Geographic Segment
  • Exhibit 19: World Market for MRI Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
  • Exhibit 20: World Market for Medical MRI Contrast Media by Geographic Segment
  • Exhibit 21: World Market for PET Radiopharmaceuticals by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
  • Exhibit 22: World Market for Medical PET Radiopharmaceuticals by Geographic Segment
  • Exhibit 23: World Market for SPECT Radiopharmaceuticals by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
  • Exhibit 24: World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment
  • Exhibit 25: Key Players’ Shares of the Worldwide Medical Contrast Media Market, 2005

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    $3,500.00 – $7,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee,...Cancer Therapeutics: The Worldwide Market , 2nd Edition
Scroll to top